-
LHN-1034 & LHN-1035: Naphthoquinone Compounds Against Drug-Resistant MRSA
Picture the last time a small cut on your hand turned red and angry. Most of us shrug it off, slap on an ointment, and move on. That easy confidence rests on a quiet assumption, that antibiotics will keep working. They aren’t, not all of them, and the cracks are showing in one of the most common bugs around, Staphylococcus aureus. Two forms of it scare doctors most. MRSA shrugs off methicillin and most other beta-lactams. QRSA shrugs off quinolones. When a strain resists both, the menu gets short fast. A team working on naphthoquinone chemistry thinks they may have found a different way in. I read the study, and…
-
Drug Repurposing for Antimicrobial Resistance: Turning Old Drugs Into New Weapons
The numbers hit hard. In 2019, bacterial antimicrobial resistance directly killed 1.27 million people. That’s more than HIV or malaria. And it contributed to nearly 5 million deaths overall. By 2050, if we keep going the way we are, we could hit 10 million deaths a year from resistant infections. The WHO has been shouting from the rooftops for years, but the pipeline for new antibiotics is still dangerously thin. There’s a reason for that, and it’s not just about the science. Developing a new antibiotic costs somewhere north of $1.6 billion and takes 10 to 17 years. And here’s the kicker: antibiotics are prescribed in short courses and held…
-
Closantel and Antibiotic Resistance: How a Sheep Dewormer Could Fight Superbugs
There’s a drug sitting in barns across the world that most human doctors have never heard of. It’s used to treat liver flukes in cattle and sheep, and it’s been around for decades. But researchers are now looking at this same drug—closantel—and wondering if it might help us fight one of the biggest threats to human health: antibiotic-resistant bacteria. The Problem Nobody Wants to Talk About Let me be direct: we’re losing the war against superbugs. The World Health Organization projects that antibiotic resistance could cause 10 million deaths every year by 2050. That number is staggering, and it’s not science fiction—it’s a conservative estimate based on current trends. Gram-negative…
-
Green Nanoparticles: Nature’s Answer to the Antibiotic Resistance Crisis
The Antibiotic Crisis Nobody Talks About Over 1.27 million people die from antibiotic-resistant infections every year. By 2050, that number could hit 10 million—surpassing cancer deaths. We’ve been in an arms race with bacteria, and the bugs are winning. Bacteria evolve fast. They swap resistance genes like trading cards, and once an antibiotic stops working, it’s usually gone for good. Meanwhile, drug development has stalled. Big pharma has largely abandoned antibiotics because they’re less profitable than chronic disease medications. But researchers are now looking at something old—nature itself—for answers. They’re synthesizing nanoparticles using plants, fungi, and algae. These “biogenic nanoparticles” could change how we fight bacterial infections. What Are Biogenic…
